Showing results (261-270 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|June 15, 2013
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 studyKrzysztof Selmaj, David K B Li, Hans-Peter Hartung, et al.
The Lancet. Neurology|February 5, 2013
Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studiesAnthony K Ngugi, Christian Bottomley, Immo Kleinschmidt, et al.
The Lancet. Neurology|July 23, 2013
Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndromeRandi Hagerman, Paul Hagerman
The Lancet. Neurology|July 23, 2013
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M Wardlaw, Eric E Smith, Geert J Biessels, et al.
The Lancet. Neurology|July 23, 2013
Joubert syndrome: congenital cerebellar ataxia with the molar toothMarta Romani, Alessia Micalizzi, Enza Maria Valente
The Lancet. Neurology|September 10, 2013
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort studyStephanie Jb Vos, Chengjie Xiong, Pieter Jelle Visser, et al.
The Lancet. Neurology|September 21, 2013
Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary preventionHugh S Markus, H Bart van der Worp, Peter M Rothwell
The Lancet. Neurology|August 17, 2013
Dolphins, dogs, and robot seals for the treatment of neurological diseaseAdrian Burton
The Lancet. Neurology|June 25, 2013
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Pageof 199